Regulation of m6A (N6-Methyladenosine) methylation modifiers in solid cancers
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Epigenetic changes, specifically N-methyladenosine (m6A) RNA methylation, are crucial in solid tumors. Targeting m6A regulators offers a novel therapeutic strategy for cancer treatment.
Area Of Science
- Molecular Oncology
- Epigenetics
- RNA Biology
Background
- Solid cancers present a significant global health challenge, necessitating a deeper understanding of their molecular underpinnings.
- N-methyladenosine (m6A) RNA methylation is an epigenetic modification increasingly recognized for its role in solid tumor biology.
- Dysregulation of m6A patterns is observed across various solid tumors, impacting key cancer-related genes and processes.
Purpose Of The Study
- To explore the role of m6A RNA methylation in the development and progression of solid tumors.
- To investigate the mechanisms by which m6A modification influences gene expression and cellular processes in cancer.
- To evaluate the therapeutic potential of targeting m6A regulators in solid tumors.
Main Methods
- Analysis of m6A modification patterns in various solid cancer types.
- Investigation of the roles of m6A 'writers', 'erasers', and 'readers' in cancer.
- Review of emerging therapeutic strategies targeting m6A regulators.
Main Results
- m6A modification patterns are significantly altered in solid tumors.
- Dysregulated m6A impacts oncogenes, tumor suppressors, cancer stem cells, metastasis, and treatment resistance.
- The interplay of m6A regulators (writers, erasers, readers) shapes the tumor methylome.
Conclusions
- m6A RNA methylation is a critical epigenetic mechanism in solid tumor progression.
- Targeting m6A regulators represents a promising novel therapeutic avenue for cancer treatment.
- Restoring or altering m6A patterns holds potential for improving treatment outcomes in solid tumors.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...